Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 19, 2023

SELL
$63.71 - $70.74 $1,656 - $1,839
-26 Reduced 0.79%
3,277 $209,000
Q4 2022

Jan 12, 2023

SELL
$68.48 - $81.09 $4,725 - $5,595
-69 Reduced 2.05%
3,303 $0
Q3 2022

Oct 25, 2022

BUY
$0.13 - $76.84 $98 - $58,091
756 Added 28.9%
3,372 $240,000
Q2 2022

Jul 25, 2022

BUY
$72.62 - $79.98 $189,973 - $209,227
2,616 New
2,616 $201,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Heartwood Wealth Advisors LLC Portfolio

Follow Heartwood Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartwood Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Heartwood Wealth Advisors LLC with notifications on news.